Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 611,429
  • Shares Outstanding, K 43,830
  • Annual Sales, $ 159,010 K
  • Annual Income, $ -21,720 K
  • EBIT $ -12 M
  • EBITDA $ -6 M
  • 60-Month Beta 1.13
  • Price/Sales 3.86
  • Price/Cash Flow N/A
  • Price/Book 6.60

Options Overview Details

View History
  • Implied Volatility 107.12% ( -9.61%)
  • Historical Volatility 47.38%
  • IV Percentile 86%
  • IV Rank 49.38%
  • IV High 215.06% on 05/02/24
  • IV Low 1.83% on 11/09/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 98
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 2,912
  • Open Int (30-Day) 2,987

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.08
  • Number of Estimates 3
  • High Estimate -0.04
  • Low Estimate -0.12
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.70 +9.84%
on 10/23/24
15.23 -8.40%
on 10/16/24
-0.36 (-2.52%)
since 10/01/24
3-Month
7.34 +90.05%
on 08/05/24
15.23 -8.40%
on 10/16/24
+5.79 (+70.96%)
since 08/01/24
52-Week
3.56 +291.85%
on 11/02/23
15.23 -8.40%
on 10/16/24
+10.34 (+286.43%)
since 11/01/23

Most Recent Stories

More News
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

AXGN : 13.95 (-0.36%)
Here's Why You Should Retain Penumbra Stock in Your Portfolio Now

Penumbra, Inc. PEN is likely to grow in the coming quarters, backed by the strength exhibited in the Thrombectomy business. The company’s robust portfolio expansion looks promising. However, the impact...

AXGN : 13.95 (-0.36%)
PEN : 233.30 (+1.94%)
PAHC : 23.18 (+0.26%)
TMDX : 82.40 (+0.52%)
BRKR Stock Might Gain From the Newly Launched OptoVolt Module

Bruker Corporation BRKR recently announced the release of its latest innovative neuroscience research solution, the OptoVolt module, at the Neuroscience 2024 conference. The module uniquely addresses...

AXGN : 13.95 (-0.36%)
BRKR : 59.29 (+4.73%)
TMDX : 82.40 (+0.52%)
KIDS : 27.36 (+3.13%)
Reasons to Retain Chemed Stock in Your Portfolio Now

Chemed Corporation CHE is expected to grow in the upcoming quarters, backed by the prospects of the VITAS business. Strength within the company’s Roto-rooter brand looks impressive. Meanwhile, Chemed’s...

AXGN : 13.95 (-0.36%)
CHE : 531.68 (-1.58%)
PAHC : 23.18 (+0.26%)
TMDX : 82.40 (+0.52%)
Reasons to Retain QIAGEN Stock in Your Portfolio for Now

QIAGEN N.V. QGEN is well-poised to grow in the coming quarter, driven by its strategic alliances with researchers and pharma companies. The company’s expansive next-generation sequencing (NSG) portfolio...

AXGN : 13.95 (-0.36%)
PAHC : 23.18 (+0.26%)
QGEN : 43.08 (+2.33%)
TMDX : 82.40 (+0.52%)
New Animal Health Products, Vaccine Sales Support PAHC Stock

Phibro Animal Health's PAHC diversified product portfolio and wide presence in key growth areas bolster our confidence in the stock. The stock carries a Zacks Rank #2 (Buy).Factors to Drive PAHC's GrowthPhibro’s...

AXGN : 13.95 (-0.36%)
PAHC : 23.18 (+0.26%)
TMDX : 82.40 (+0.52%)
KIDS : 27.36 (+3.13%)
Here's Why You Should Hold IART Stock in Your Portfolio Now

Integra LifeSciences Holdings Corporation IART is well-poised to grow in the coming quarter, driven by healthy sales growth within its Tissue Technologies business despite product recall and manufacturing...

AXGN : 13.95 (-0.36%)
IART : 19.28 (+2.77%)
PAHC : 23.18 (+0.26%)
TMDX : 82.40 (+0.52%)
HYPR Achieves Positive Swoop System Data for ECMO: Stock to Rise?

Hyperfine, Inc. HYPR recently announced a publication by investigators at Johns Hopkins Hospital and the University of Texas-Houston on using the Swoop system for patients on extracorporeal membrane oxygenation...

AXGN : 13.95 (-0.36%)
HYPR : 0.9800 (+0.14%)
TMDX : 82.40 (+0.52%)
KIDS : 27.36 (+3.13%)
Should You Continue to Hold Bio-Rad Stock in Your Portfolio?

Bio-Rad Laboratories, Inc.’s BIO robust QX600 Droplet Digital PCR (ddPCR) platform positions the company well to capture a major share in the booming digital PCR space. The clinical diagnostics business...

AXGN : 13.95 (-0.36%)
BIO : 368.42 (+2.86%)
PAHC : 23.18 (+0.26%)
TMDX : 82.40 (+0.52%)
VRNOF Stock Likely to Gain From Its Newly Opened Dispensary in Phoenix

Verano Holdings Corp. VRNOF announced the opening of Zen Leaf Arcadia in Phoenix, AZ, today.  Representatives of the Greater Phoenix Chamber of Commerce will be present at the ribbon-cutting ceremony....

AXGN : 13.95 (-0.36%)
TMDX : 82.40 (+0.52%)
VRNOF : 3.3500 (+3.40%)
KIDS : 27.36 (+3.13%)

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

3rd Resistance Point 14.51
2nd Resistance Point 14.38
1st Resistance Point 14.16
Last Price 13.95
1st Support Level 13.81
2nd Support Level 13.68
3rd Support Level 13.46

See More

52-Week High 15.23
Last Price 13.95
Fibonacci 61.8% 10.77
Fibonacci 50% 9.39
Fibonacci 38.2% 8.02
52-Week Low 3.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar